Sona Nanotech Company Description

Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing.

It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests.

The company was founded in 2013 and is based in Halifax, Canada.

Sona Nanotech Inc.

Country	Canada
Founded	2013
Industry	Diagnostics & Research
Sector	Healthcare
CEO	David Regan

Contact Details

Address: Purdy’s Wharf Tower II Halifax, NS B3J 3R7 Canada
Phone	902-442-0653
Website	sonanano.com

Stock Details

Ticker Symbol	SONA
Exchange	Canadian Securities Exchange
Fiscal Year	November - October
Reporting Currency	CAD
ISIN Number	CA83541C1059
SIC Code	1000

Key Executives

Name	Position
David Andrew Regan	Chief Executive Officer
Robert William George Randall CPA	Chief Financial Officer and Corporate Secretary
Dr. Len Pagliaro Ph.D.	CSO and Director
Dr. Carman Giacomantonio M.D., M.Sc.	Chief Medical Officer
Dr. Kulbir Singh Ph.D.	Co-Founder and Head of Research & Development
Dr. Mike McAlduff	Director of Research & Development and Production and Founder
Dr. Gerrard Marangoni	Co-Founder and Member of Scientific Advisory Board
Darren Rowles	Head of Diagnostics